Grace Therapeutics, Inc.
GRCENasdaqCIK 1444192HealthcareFiscal year ends Mar 31
Reports and events: 372 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-08-1210:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-005872 |
| 2021-08-1210:56 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001171843-21-005871 |
| 2021-07-2308:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-21-005045 |
| 2021-07-2117:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-21-004979 |
| 2021-06-2207:00 ET | 10-K | Annual reportPeriod 2021-03-31 | 0001171843-21-004462 |
| 2021-06-2207:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-004460 |
| 2021-05-1707:11 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-21-003558 |
| 2021-05-0707:09 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-21-003288 |
| 2021-03-0917:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-21-001601 |
| 2021-02-0916:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-000882 |
| 2021-02-0907:00 ET | 10-Q | Quarterly reportPeriod 2020-12-31 | 0001171843-21-000849 |
| 2021-01-2707:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-21-000518 |
| 2020-12-0408:00 ET | 8-K | 8.01 Other events | 0001171843-20-008355 |
| 2020-11-1607:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-20-008003 |
| 2020-11-1607:00 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001171843-20-008002 |
| 2020-10-0707:30 ET | 8-K | 3.01 Delisting notice | 0001171843-20-006922 |
| 2020-10-0215:39 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-20-006824 |
| 2020-09-2908:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-20-006713 |
| 2020-09-1821:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-20-006507 |
| 2020-09-1107:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-20-006409 |
| 2020-09-0916:00 ET | DEF 14A | Proxy statementPeriod 2020-09-30 | 0001171843-20-006363 |
| 2020-08-3116:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-20-006188 |
| 2020-08-1308:30 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001171843-20-005901 |
| 2020-08-1308:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-20-005899 |
| 2020-07-3116:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-20-005439 |
| 2020-06-3009:01 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-20-004630 |
| 2020-06-2916:02 ET | 10-K | Annual reportPeriod 2020-03-31 | 0001171843-20-004613 |
| 2020-06-2912:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-20-004607 |
| 2020-06-1909:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-20-004446 |
| 2020-04-3016:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-20-003135 |
| 2020-04-2016:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-20-002717 |
| 2020-04-0117:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-20-002270 |
| 2020-03-1108:00 ET | 6-K | Report of a foreign private issuerPeriod 2020-03-11 | 0001171843-20-001625 |
| 2020-02-2817:00 ET | 6-K | Report of a foreign private issuerPeriod 2020-02-28 | 0001171843-20-001384 |
| 2020-02-1408:00 ET | 6-K | Report of a foreign private issuerPeriod 2020-02-14 | 0001171843-20-000982 |
| 2020-02-1408:00 ET | 6-K | Report of a foreign private issuerPeriod 2020-02-13 | 0001171843-20-000981 |
| 2020-02-1309:00 ET | 6-K | Report of a foreign private issuerPeriod 2020-02-13 | 0001171843-20-000950 |
| 2020-02-1007:00 ET | 6-K | Report of a foreign private issuerPeriod 2020-02-10 | 0001171843-20-000806 |
| 2020-01-1306:21 ET | 6-K | Report of a foreign private issuerPeriod 2020-01-13 | 0001171843-20-000177 |
| 2019-12-2420:43 ET | 6-K | Report of a foreign private issuerPeriod 2019-12-23 | 0001171843-19-008308 |
| 2019-11-2607:58 ET | 6-K | Report of a foreign private issuerPeriod 2019-11-26 | 0001171843-19-007828 |
| 2019-11-1808:46 ET | 6-K | Report of a foreign private issuerPeriod 2019-11-18 | 0001171843-19-007619 |
| 2019-11-1307:55 ET | 6-K | Report of a foreign private issuerPeriod 2019-09-30 | 0001171843-19-007485 |
| 2019-11-1307:55 ET | 6-K | Report of a foreign private issuerPeriod 2019-11-13 | 0001171843-19-007484 |
| 2019-11-0708:42 ET | 6-K | Report of a foreign private issuerPeriod 2019-11-07 | 0001171843-19-007299 |
| 2019-11-0609:39 ET | 6-K | Report of a foreign private issuerPeriod 2019-11-06 | 0001171843-19-007218 |
| 2019-11-0409:24 ET | 6-K | Report of a foreign private issuerPeriod 2019-11-04 | 0001171843-19-007107 |
| 2019-10-0109:00 ET | 6-K | Report of a foreign private issuerPeriod 2019-10-01 | 0001171843-19-006227 |
| 2019-09-3008:37 ET | 6-K | Report of a foreign private issuerPeriod 2019-09-30 | 0001171843-19-006188 |
| 2019-09-0908:41 ET | 6-K | Report of a foreign private issuerPeriod 2019-09-09 | 0001171843-19-005862 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:10 ET. Listed shows no prices and gives no investment advice.